Clinical Trials at University of Louisville
As of August 2026, 57 paid clinical trials are recruiting at University of Louisville, located at 530 S JACKSON ST, LOUISVILLE, KY 40202-1675, phone (502) 852-5851 in Louisville, Kentucky. Active studies at this site cover conditions such as Obesity, Acute Myeloid Leukemia and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Louisville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
58 clinical trials at University of Louisville
·Clear filters·A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Treatment of Moderate to Severe Refractory Crohn's Disease
A Study of BI 3810944 in Patients With Advanced Cancer
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Stroke Thrombectomy and Aneurysm Registry
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Gastroparesis Registry 4
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
Common conditions studied in Louisville
- Obesity (12 active studies)
- Acute Myeloid Leukemia (11 active studies)
- Heart Failure (11 active studies)
- Overweight (9 active studies)
- Head and Neck Squamous Cell Carcinoma (8 active studies)
- Breast Cancer (7 active studies)
Leading research sponsors in Louisville
- University of Louisville
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Louisville?
There are approximately 491 recruiting clinical trials in Louisville, Kentucky listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Louisville pay participants?
Most recruiting trials in Louisville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Louisville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Louisville?
The most common conditions under active study in Louisville include Obesity (12), Acute Myeloid Leukemia (11), Heart Failure (11), Overweight (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Louisville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Louisville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Louisville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Louisville?
Recruiting research sites in Louisville include University of Louisville, The James Graham Brown Cancer Center at University of Louisville, Norton Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Louisville right now?
The largest active categories in Louisville are Cancer & tumors (176), Cardiovascular (40), Diabetes & metabolic (33). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Louisville?
University of Louisville is located at 530 S JACKSON ST, LOUISVILLE, KY 40202-1675. Use the Google Maps link in the intro above to get directions.
How do I contact University of Louisville?
You can reach University of Louisville by phone at (502) 852-5851. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.